These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 31952459)

  • 21. [Prevention and treatment of antipsychotic induced weight gain].
    Veerman SRT; Cohen D
    Tijdschr Psychiatr; 2023; 65(4):259-265. PubMed ID: 37323046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice.
    De Hert M; Dobbelaere M; Sheridan EM; Cohen D; Correll CU
    Eur Psychiatry; 2011 Apr; 26(3):144-58. PubMed ID: 21295450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
    Lee SY; Park MH; Patkar AA; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):490-6. PubMed ID: 21146575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials.
    Wu H; Siafis S; Hamza T; Schneider-Thoma J; Davis JM; Salanti G; Leucht S
    Schizophr Bull; 2022 May; 48(3):643-654. PubMed ID: 35137229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
    Moreno C; Merchán-Naranjo J; Alvarez M; Baeza I; Alda JA; Martínez-Cantarero C; Parellada M; Sánchez B; de la Serna E; Giráldez M; Arango C
    Bipolar Disord; 2010 Mar; 12(2):172-84. PubMed ID: 20402710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-generation antipsychotics for major depressive disorder and dysthymia.
    Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.
    Brandl EJ; Frydrychowicz C; Tiwari AK; Lett TA; Kitzrow W; Büttner S; Ehrlich S; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ; Puls I
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):134-41. PubMed ID: 22426215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Off-label second generation antipsychotics for impulse regulation disorders: a review.
    Scheltema Beduin A; de Haan L
    Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis.
    Arango C; Ng-Mak D; Finn E; Byrne A; Loebel A
    Eur Child Adolesc Psychiatry; 2020 Sep; 29(9):1195-1205. PubMed ID: 31758359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat.
    Gao K; Yuan C; Wu R; Chen J; Wang Z; Fang Y; Calabrese JR
    Neurosci Bull; 2015 Oct; 31(5):572-88. PubMed ID: 26024955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting antipsychotic-induced weight gain in first episode psychosis - A field-wide systematic review and meta-analysis of non-genetic prognostic factors.
    Fitzgerald I; Sahm LJ; Byrne A; O'Connell J; Ensor J; Ní Dhubhlaing C; O'Dwyer S; Crowley EK
    Eur Psychiatry; 2023 Jun; 66(1):e42. PubMed ID: 37278237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review.
    Solmi M; Miola A; Capone F; Pallottino S; Højlund M; Firth J; Siskind D; Holt RIG; Corbeil O; Cortese S; Dragioti E; Du Rietz E; Nielsen RE; Nordentoft M; Fusar-Poli P; Hartman CA; Høye A; Koyanagi A; Larsson H; Lehto K; Lindgren P; Manchia M; Skonieczna-Żydecka K; Stubbs B; Vancampfort D; Vieta E; Taipale H; Correll CU;
    Expert Opin Drug Saf; 2024 Oct; 23(10):1249-1269. PubMed ID: 39225182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.
    Bobes J; Rejas J; Garcia-Garcia M; Rico-Villademoros F; García-Portilla MP; Fernández I; Hernández G;
    Schizophr Res; 2003 Jul; 62(1-2):77-88. PubMed ID: 12765747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a 'weight neutral' second-generation antipsychotic for bipolar disorder?
    Fang F; Wang Z; Wu R; Calabrese JR; Gao K
    Expert Rev Neurother; 2017 Apr; 17(4):407-418. PubMed ID: 28005435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed.
    Shams TA; Müller DJ
    Curr Psychiatry Rep; 2014 Oct; 16(10):473. PubMed ID: 25138234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.
    Lett TA; Wallace TJ; Chowdhury NI; Tiwari AK; Kennedy JL; Müller DJ
    Mol Psychiatry; 2012 Mar; 17(3):242-66. PubMed ID: 21894153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis.
    Ostacher M; Ng-Mak D; Patel P; Ntais D; Schlueter M; Loebel A
    World J Biol Psychiatry; 2018 Dec; 19(8):586-601. PubMed ID: 28264635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain.
    Maciukiewicz M; Gorbovskaya I; Tiwari AK; Zai CC; Freeman N; Meltzer HY; Kennedy JL; Müller DJ
    J Neural Transm (Vienna); 2019 Jan; 126(1):27-33. PubMed ID: 30229349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.